Monika L Page, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 132 Central St, Foxboro, MA 02035 Phone: 508-543-6306 |
Nancy T Callan, PNP Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 132 Central Street, Ste 116, Foxboro, MA 02035 Phone: 508-543-6306 |
Robert J Henry, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 132 Central St, Suite 116, Foxboro, MA 02035 Phone: 508-543-6306 Fax: 508-543-2976 |
Judith A Shea-vaillancourt, CFNP Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 132 Central St, Ste 116, Foxboro, MA 02035 Phone: 508-543-6306 Fax: 508-543-2976 |
Christopher P Giuliano, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 132 Central St, Ste 116, Foxboro, MA 02035 Phone: 508-543-6306 Fax: 508-543-2976 |
Olivia S Kim, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 132 Central St, Suite 116, Foxboro, MA 02035 Phone: 508-543-6306 Fax: 508-543-2976 |
Arthur A Giuliano, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 132 Central Street, Suite 116, Foxboro, MA 02035 Phone: 508-543-6306 Fax: 508-543-2976 |
Ys Dooley Chen, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 132 Central St, Suite 116, Foxboro, MA 02035 Phone: 508-543-6306 Fax: 508-543-2976 |
Leah S Spitzer, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 132 Central St, Suite 116, Foxboro, MA 02035 Phone: 508-543-6306 Fax: 508-543-2976 |
Dianne A Pacheco, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 132 Central St, Suite 116, Foxboro, MA 02035 Phone: 508-543-6306 Fax: 508-543-2976 |
News Archive
Manhattan Scientifics, Inc. (OTCBB: MHTX) announced the signing of a contract with Carpenter Technology Corporation (NYSE: CRS), wherein Carpenter will fully develop, manufacture and market a new class of high strength metals under an exclusive license from Manhattan Scientifics and the Los Alamos National Laboratory. The contract includes minimum annual payments to Manhattan Scientifics during a 4-year period, together with royalty payments as a percent of gross sales.
The latest issue in the From Policy to Practice report series from The Gerontological Society of America addresses recent labeling changes for OTC analgesics and highlights important considerations when recommending the use of these products in older adults.
The risk for hip fractures among elderly individuals increases during the first 45 days after initiating antihypertensive medication, and significantly so for those who start angiotensin II converting-enzyme inhibitors and beta-adrenergic blockers, report Canadian researchers.
pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has submitted a Marketing Authorization Application (MAA) to the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom (UK) for Iluvien®.
› Verified 6 days ago